Dihydropyridine calcium channel blockers and peripheral side effects

被引：0
|
作者：
A Sirker
CG Missouris
GA MacGregor
机构：
[1] Blood Pressure Unit,Department of Medicine
[2] St Georges Hospital Medical School,undefined
来源：
Journal of Human Hypertension | 2001年 / 15卷
关键词：
dihydropyridine; calcium channel blockers;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：745 / 746
页数：1
相关论文
共 50 条
  • [21] Risk factors for peripheral edema development in hypertensive patients treated with dihydropyridine calcium channel blockers - the smoking paradox
    Chatzistamatiou, E.
    Liakos, C.
    Antoniadou, A.
    Moustakas, G.
    Kalovidouris, N.
    Rodolakis, N.
    Vagena, I. Babatseva
    Bakogiannis, C.
    Stefanadis, C.
    Kallikazaros, I.
    EUROPEAN HEART JOURNAL, 2010, 31 : 533 - 534
  • [22] THE INTERACTION OF DIHYDROPYRIDINE CALCIUM-CHANNEL BLOCKERS WITH CALMODULIN AND CALMODULIN INHIBITORS
    THAYER, SA
    FAIRHURST, AS
    MOLECULAR PHARMACOLOGY, 1983, 24 (01) : 6 - 9
  • [23] Dihydropyridine Calcium Channel Blockers and the Risk of Severe COVID-19
    Mendez, Sean R.
    Frank, Rachel C.
    Stevenson, Elizabeth K.
    Chung, Mabel
    Silverman, Michael G.
    CHEST, 2021, 160 (01) : 89 - 93
  • [24] Separation of five dihydropyridine calcium channel blockers by micellar electrokinetic chromatography
    Wang, J
    Chen, HF
    Zhao, LF
    CHINESE JOURNAL OF ANALYTICAL CHEMISTRY, 1999, 27 (01) : 82 - 84
  • [25] Dihydropyridine calcium-channel blockers for the treatment of hypertensive diabetic patients
    Staessen, JA
    Birkenhäger, WH
    Fagard, RH
    EUROPEAN HEART JOURNAL, 2000, 21 (01) : 2 - 7
  • [26] Time course for blood pressure lowering of dihydropyridine calcium channel blockers
    Ghamami, Niousha
    Chiang, Sandy Hsiang Yu
    Dormuth, Colin
    Wright, James M.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2014, (08):
  • [27] Clinical and economic consequences of reference pricing for dihydropyridine calcium channel blockers
    Schneeweiss, S
    Soumerai, SB
    Maclure, M
    Dormuth, C
    Walker, AM
    Glynn, RJ
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2003, 74 (04) : 388 - 400
  • [28] Effect of dihydropyridine calcium channel blockers on blood pressure variability in the SPRINT trial: a treatment effects approach
    de Havenon, Adam
    Petersen, Nils
    Wolcott, Zoe
    Goldstein, Eric
    Delic, Alen
    Sheibani, Nazanin
    Anadani, Mohammad
    Sheth, Kevin N.
    Lansberg, Maarten
    Turan, Tanya
    Prabhakaran, Shyam
    JOURNAL OF HYPERTENSION, 2022, 40 (03) : 462 - 469
  • [29] Differential effects of dihydropyridine calcium channel blockers in kainic acid-induced experimental seizures in rats
    Kriz, J
    Zupan, G
    Simonic, A
    EPILEPSY RESEARCH, 2003, 52 (03) : 215 - 225
  • [30] DIFFERENTIAL-EFFECTS OF 1,4-DIHYDROPYRIDINE CALCIUM-CHANNEL BLOCKERS - THERAPEUTIC IMPLICATIONS
    KATZ, AM
    LEACH, NM
    JOURNAL OF CLINICAL PHARMACOLOGY, 1987, 27 (11): : 825 - 834
12345